Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Vineet Laboratories's Enterprise Value is ₹990 Mil.
Vineet Laboratories's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹51 Mil. Therefore, Vineet Laboratories's EV-to-EBIT ratio for today is 19.24.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Vineet Laboratories's Enterprise Value is ₹990 Mil.
Vineet Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹77 Mil. Therefore, Vineet Laboratories's EV-to-EBITDA ratio for today is 12.92.
Vineet Laboratories Enterprise Value Historical Data
The historical data trend for Vineet Laboratories's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Vineet Laboratories's Enterprise Value
For the Chemicals subindustry, Vineet Laboratories's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vineet Laboratories's Enterprise Value Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Vineet Laboratories's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Vineet Laboratories's Enterprise Value falls into.
Vineet Laboratories Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Vineet Laboratories's Enterprise Value for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vineet Laboratories (NSE:VINEETLAB) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Vineet Laboratories's current Enterprise Value is ₹990 Mil.
Vineet Laboratories's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹51 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Vineet Laboratories's current Enterprise Value is ₹990 Mil.
Vineet Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹77 Mil.
Vineet Laboratories's current Enterprise Value is ₹990 Mil.
Vineet Laboratories's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,506 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vineet Laboratories Enterprise Value Related Terms
Thank you for viewing the detailed overview of Vineet Laboratories's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Vineet Laboratories (NSE:VINEETLAB) Business Description
Vineet Laboratories Ltd Formerly known as Ortin Laboratories Limited, Unit-II is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Isopropyl-beta-D-thiogalactopyranoside and Nitrophenyl phosphate disodium salt among others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, manufacture of Drug Intermediates & Bulk Dugs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:VINEETLAB has been successfully added to your 